Cogent Biosciences Inc. (COGT)
Cogent Biosciences Statistics
Share Statistics
Cogent Biosciences has 113.86M shares outstanding. The number of shares has increased by 19.07% in one year.
| Shares Outstanding | 113.86M |
| Shares Change (YoY) | 19.07% |
| Shares Change (QoQ) | 3.07% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 95.39M |
| Failed to Deliver (FTD) Shares | 1.83K |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 14.33M, so 12.59% of the outstanding shares have been sold short.
| Short Interest | 14.33M |
| Short % of Shares Out | 12.59% |
| Short % of Float | 14.74% |
| Short Ratio (days to cover) | 8.05 |
Valuation Ratios
The PE ratio is -3.17 and the forward PE ratio is -2.81. Cogent Biosciences's PEG ratio is -0.07.
| PE Ratio | -3.17 |
| Forward PE | -2.81 |
| PS Ratio | 0 |
| Forward PS | 1.1 |
| PB Ratio | 3.16 |
| P/FCF Ratio | -3.89 |
| PEG Ratio | -0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cogent Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.32 |
| Quick Ratio | 5.32 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.25M |
| Employee Count | 205 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -22.63% in the last 52 weeks. The beta is 0.2, so Cogent Biosciences's price volatility has been higher than the market average.
| Beta | 0.2 |
| 52-Week Price Change | -22.63% |
| 50-Day Moving Average | 6.09 |
| 200-Day Moving Average | 8.74 |
| Relative Strength Index (RSI) | 56.3 |
| Average Volume (20 Days) | 1.37M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -275.94M |
| Net Income | -255.86M |
| EBITDA | -275.94M |
| EBIT | -275.94M |
| Earnings Per Share (EPS) | -3.49 |
Balance Sheet
The company has 98.17M in cash and 17.47M in debt, giving a net cash position of 80.7M.
| Cash & Cash Equivalents | 98.17M |
| Total Debt | 17.47M |
| Net Cash | 80.7M |
| Retained Earnings | -859.48M |
| Total Assets | 327.9M |
| Working Capital | 240.76M |
Cash Flow
In the last 12 months, operating cash flow was -207.79M and capital expenditures 0, giving a free cash flow of -208.36M.
| Operating Cash Flow | -207.79M |
| Capital Expenditures | 0 |
| Free Cash Flow | -208.36M |
| FCF Per Share | -2.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for COGT is $14.5, which is 157.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.5 |
| Price Target Difference | 157.1% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Nov 9, 2020. It was a backward split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | -1.14 |
| Piotroski F-Score | 1 |